Defining value - part 2

In this lesson

1. 0:00 Stakeholder analysis in pharmaceutical context
2. 1:18 Assessing power, legitimacy and urgency dimensions
3. 2:58 Ranking customers and government as key stakeholders
4. 5:34 Understanding Mendelow's Matrix framework
5. 6:07 Mapping stakeholders to power and interest levels
6. 10:10 Review of balanced scorecard and business model alignment
7. 12:53 Summary of stakeholder analysis and value definition

About this lesson

You'll discover why this matters for Strategic Business Leader (SBL) and other strategic papers—understanding who your key stakeholders are is essential to defining value and shaping organisational strategy. The lesson uses a practical pharmaceutical company case study to show you how to apply both methods. First, you'll see how to rank stakeholders across power, legitimacy, and urgency to determine their priority level. Then you'll explore Mendelow's Matrix, which segments stakeholders into four categories: minimal effort, keep informed, keep satisfied, and key players. Each framework gives you a different lens on stakeholder importance, and together they help you avoid overlooking critical groups or wasting effort on those with minimal impact. You'll also see how stakeholder analysis connects to the balanced scorecard and business model—showing you how the customer perspective, internal business processes, and innovation and learning all map onto different stakeholder groups and stages of value creation. By the end, you'll have a structured, practical approach to stakeholder prioritisation that you can apply to case study scenarios and real business decisions.

Duration: 14m